184 related articles for article (PubMed ID: 38528631)
1. Head and neck cancer of unknown primary: unveiling primary tumor sites through machine learning on DNA methylation profiles.
Stark L; Kasajima A; Stögbauer F; Schmidl B; Rinecker J; Holzmann K; Färber S; Pfarr N; Steiger K; Wollenberg B; Ruland J; Winter C; Wirth M
Clin Epigenetics; 2024 Mar; 16(1):47. PubMed ID: 38528631
[TBL] [Abstract][Full Text] [Related]
2. Utility of UV Signature Mutations in the Diagnostic Assessment of Metastatic Head and Neck Carcinomas of Unknown Primary.
Furlan KC; Saeed-Vafa D; Mathew TM; Saller JJ; Tabbara SO; Boyle TA; Wenig BM; Hernandez-Prera JC
Head Neck Pathol; 2024 Feb; 18(1):11. PubMed ID: 38393464
[TBL] [Abstract][Full Text] [Related]
3. Podoplanin expression in lymph node metastases of head and neck cancer and cancer of unknown primary patients.
Kühn JP; Bochen F; Körner S; Schick B; Wagner M; Smola S; Berkó-Göttel B; Morris LGT; Wang J; Bozzato A; Linxweiler M
Int J Biol Markers; 2022 Sep; 37(3):280-288. PubMed ID: 35880270
[TBL] [Abstract][Full Text] [Related]
4. Machine learning models predict the primary sites of head and neck squamous cell carcinoma metastases based on DNA methylation.
Leitheiser M; Capper D; Seegerer P; Lehmann A; Schüller U; Müller KR; Klauschen F; Jurmeister P; Bockmayr M
J Pathol; 2022 Apr; 256(4):378-387. PubMed ID: 34878655
[TBL] [Abstract][Full Text] [Related]
5. Unknown primary head and neck squamous cell carcinoma: molecular identification of the site of origin.
Califano J; Westra WH; Koch W; Meininger G; Reed A; Yip L; Boyle JO; Lonardo F; Sidransky D
J Natl Cancer Inst; 1999 Apr; 91(7):599-604. PubMed ID: 10203278
[TBL] [Abstract][Full Text] [Related]
6. The use of an immunohistochemical diagnostic panel to determine the primary site of cervical lymph node metastases of occult squamous cell carcinoma.
Park JM; Jung CK; Choi YJ; Lee KY; Kang JH; Kim MS; Hu HJ
Hum Pathol; 2010 Mar; 41(3):431-7. PubMed ID: 19954817
[TBL] [Abstract][Full Text] [Related]
7. Machine learning analysis of DNA methylation profiles distinguishes primary lung squamous cell carcinomas from head and neck metastases.
Jurmeister P; Bockmayr M; Seegerer P; Bockmayr T; Treue D; Montavon G; Vollbrecht C; Arnold A; Teichmann D; Bressem K; Schüller U; von Laffert M; Müller KR; Capper D; Klauschen F
Sci Transl Med; 2019 Sep; 11(509):. PubMed ID: 31511427
[TBL] [Abstract][Full Text] [Related]
8.
Sailer V; Holmes EE; Gevensleben H; Goltz D; Dröge F; Franzen A; Dietrich J; Kristiansen G; Bootz F; Schröck A; Dietrich D
Clin Epigenetics; 2017; 9():12. PubMed ID: 28174607
[TBL] [Abstract][Full Text] [Related]
9. A model and nomogram to predict tumor site origin for squamous cell cancer confined to cervical lymph nodes.
Ali AN; Switchenko JM; Kim S; Kowalski J; El-Deiry MW; Beitler JJ
Cancer; 2014 Nov; 120(22):3469-76. PubMed ID: 25060659
[TBL] [Abstract][Full Text] [Related]
10. Intragenic DNA methylation of PITX1 and the adjacent long non-coding RNA C5orf66-AS1 are prognostic biomarkers in patients with head and neck squamous cell carcinomas.
Sailer V; Charpentier A; Dietrich J; Vogt TJ; Franzen A; Bootz F; Dietrich D; Schroeck A
PLoS One; 2018; 13(2):e0192742. PubMed ID: 29425237
[TBL] [Abstract][Full Text] [Related]
11. Unique DNA methylation loci distinguish anatomic site and HPV status in head and neck squamous cell carcinoma.
Lleras RA; Smith RV; Adrien LR; Schlecht NF; Burk RD; Harris TM; Childs G; Prystowsky MB; Belbin TJ
Clin Cancer Res; 2013 Oct; 19(19):5444-55. PubMed ID: 23894057
[TBL] [Abstract][Full Text] [Related]
12. Head and Neck Squamous Cell Carcinoma of Unknown Primary: A Diagnostic Work-Up.
Manoharan M; Kalman NS; Rabinowits G
Oncologist; 2024 Mar; 29(3):192-199. PubMed ID: 37995312
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic utility of p16 immunocytochemistry in metastatic cervical lymph nodes in head and neck cancers.
Kapoor D; Handa U; Kundu R; Das A
Diagn Cytopathol; 2021 Apr; 49(4):469-474. PubMed ID: 33428334
[TBL] [Abstract][Full Text] [Related]
14. Origin of cystic squamous cell carcinoma metastases in head and neck lymph nodes: Addition of EBV testing improves diagnostic accuracy.
Švajdler M; Kašpírková J; Hadravský L; Laco J; Dubinský P; Straka Ľ; Ondič O; Michal M; Skálová A
Pathol Res Pract; 2016 Jun; 212(6):524-31. PubMed ID: 27013059
[TBL] [Abstract][Full Text] [Related]
15. Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma.
Misawa K; Misawa Y; Kondo H; Mochizuki D; Imai A; Fukushima H; Uehara T; Kanazawa T; Mineta H
PLoS One; 2015; 10(3):e0118588. PubMed ID: 25734919
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of the methylation of Wnt pathway antagonists-CXXC4, DACT2, and the inhibitors of sonic hedgehog signaling-ZIC1, ZIC4, and HHIP in head and neck squamous cell carcinomas.
Paluszczak J; Wiśniewska D; Kostrzewska-Poczekaj M; Kiwerska K; Grénman R; Mielcarek-Kuchta D; Jarmuż-Szymczak M
Clin Oral Investig; 2017 Jun; 21(5):1777-1788. PubMed ID: 27553089
[TBL] [Abstract][Full Text] [Related]
17. Staging of head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node metastases.
Cortesina G; Martone T; Galeazzi E; Olivero M; De Stefani A; Bussi M; Valente G; Comoglio PM; Di Renzo MF
Int J Cancer; 2000 May; 89(3):286-92. PubMed ID: 10861506
[TBL] [Abstract][Full Text] [Related]
18. Tissue of origin prediction for cancer of unknown primary using a targeted methylation sequencing panel.
Sun M; Xu B; Chen C; Zhu Y; Li X; Chen K
Clin Epigenetics; 2024 Feb; 16(1):25. PubMed ID: 38336771
[TBL] [Abstract][Full Text] [Related]
19. Hybrid Capture 2 human papillomavirus testing of fine needle aspiration cytology of head and neck squamous cell carcinomas.
Hakima L; Adler E; Prystowsky M; Schiff B; Schlecht N; Fox A; Suhrland M; Khader SN
Diagn Cytopathol; 2015 Sep; 43(9):683-7. PubMed ID: 25964135
[TBL] [Abstract][Full Text] [Related]
20. Unknown primary head and neck cancer treated with intensity-modulated radiation therapy: to what extent the volume should be irradiated.
Lu H; Yao M; Tan H
Oral Oncol; 2009 Jun; 45(6):474-9. PubMed ID: 18804408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
